Les "Questions et réponses sur les évangiles" d'Eusèbe de Césarée: étude et édition du résumé grec

Cette thèse propose la première édition critique de l?une des traditions les plus importantes des Questions et réponses sur les évangiles d?Eusèbe de Césarée, dont l?original est perdu. Il s?agit de l?édition du manuscrit contenant l?anthologie grecque du manuscrit Vaticanus Pal. Gr. 220. Cette anthologie est composée presque intégralement d?une suite d?extraits du texte original, non résumés, dont l?auteur n?est pas Eusèbe et dont la date ne peut pas être reportée avant le V-VIème siècle. Cette édition est accompagnée par une traduction française, la première dans une langue moderne, ainsi que d?une introduction concernant le contexte historique et d?un commentaire visant à comparer l?anthologie avec les autres traditions fragmentaires ainsi qu?à étudier les sources et la fortune de ce texte eusébien.

Quelles questions émergentes pour les politiques publiques de biodiversité en France métropolitaine? Résultats et perspectives

Dans un contexte en constante évolution, l'élaboration, la mise en oeuvre et l'évaluation des politiques publiques de biodiversité nécessitent d'anticiper les changements futurs possibles afin de pouvoir se préparer à temps. Or les informations concernant ces changements sont nombreuses et les enjeux qui pourraient s'avérer importants à l'avenir sont souvent peu visibles. Pour répondre à ce défi, une expertise multi-acteurs et multidisciplinaire s'inspirant des démarches d'horizon scanning et intitulée BioPIQue 2013 a permis d'identifier 25 questions émergentes, dont 10 questions stratégiques, pour les politiques publiques de biodiversité en France métropolitaine d'ici à 2020. Ces questions émergentes sont autant d'opportunités et de risques que l'ensemble es acteurs qui souhaitent avancer vers une plus grande prise en compte des enjeux de biodiversité peuvent saisir.

Questions of Scale in Economic Experiments

Questions of scale have received ample attention in physical scale modeling and experimentation, but have not been discussed with regard to economic experimentation. In this article I distinguish between two kinds of experiments, "generic" and "specific" experiments. Using a comparison between two experimental laboratory studies on the "posted price effect", I then show that scale issues become important in specific laboratory experiments because of the scaling down of time in the target market to laboratory dimensions. This entails choices in the material configuration of the experiment as well as role changes of experimental subjects. My discussion thus adds to recent literature on external validity and on the materiality of experiments.

Le vaccin contre le Zona : vos questions et leurs réponses [The vaccine against shingle: Your questions and their answers]

Depuis 2006, le vaccin vivant atténué contre le zona dispose d'une autorisation de mise sur le marché au niveau européen. Depuis le 15 juin 2015, il est enfin disponible en France au prix de 127,24 euro et remboursé à 30 % par l'assurance maladie. Cet article répond à vos interrogations concernant son intérêt, son efficacité, sa tolérance et ses bénéfices pour la société, dans la prévention du zona et d'une de ses complications les plus fréquentes et la plus invalidante, les douleurs post-zostériennes. Since 2006, the live attenuated vaccine against shingles has had market authorisation in the European Union. Since June 15th 2015, it is available in France for the price of 127.24 euro and will be reimbursed by the National Health Insurance System. This article answers your questions about its interest, efficacy, tolerance and benefits to society in the prevention of shingles and one of its the most frequent and most disabling complications: post-herpetic neuralgia.

Zostavax, le vaccin contre le Zona : vos questions et leurs réponses [Zostavax, the vaccine against shingle: Your questions and their answers]

Depuis 2007, le vaccin vivant atténué contre le zona, dispose d'une autorisation de mise sur le marché au niveau européenne. Il sera enfin bientôt disponible en Suisse. Cet article répond à vos interrogations concernant son intérêt, son efficacité, sa tolérance et ses bénéfices pour la société, dans la prévention du zona et d'une de ses complications les plus fréquentes et la plus invalidante les douleurs post-zostériennes.

Continuing Medical Education Self-Assessment Questions Vol. 50, No. 2 - April 2014. Focal vibration in neurorehabilitation.

During the last decade, many studies have been carried out to understand the effects of focal vibratory stimuli at various levels of the central nervous system and to study pathophysiological mechanisms of neurological disorders as well as the therapeutic effects of focal vibration in neurorehabilitation. This review aimed to describe the effects of focal vibratory stimuli in neurorehabilitation including the neurological diseases or disorders like stroke, spinal cord injury, multiple sclerosis, Parkinson's' disease and dystonia. In conclusion, focal vibration stimulation is well tolerated, effective and easy to use, and it could be used to reduce spasticity, to promote motor activity and motor learning within a functional activity, even in gait training, independent from etiology of neurological pathology. Further studies are needed in the future well- designed trials with bigger sample size to determine the most effective frequency, amplitude and duration of vibration application in the neurorehabilitation.

Continuing Medical Education Self-Assessment Questions Vol. 50, No. 1 - January 2014. Actual evidence in the medical approach to adolescents with idiopathic scoliosis

Idiopathic scoliosis (IS) is a three-dimensional deformity of the spine and trunk. The most common form involve ado- lescents (AIS). The prevalence for AIS is 2-3% of the population, with 1 out of 6 patients requiring treatment of which 25% progress to surgery. Physical and rehabilitation medicine (PRM) plays a primary role in the so-called conservative treatment of adolescents with AIS, since all the therapeutic tools used (exercises and braces) fall into the PRM domain. According to a Cochrane systematic review there is evidence in favor of bracing, even if it is of low quality. Another shows that there is evidence in favor of exercises as an adjunctive treatment, but of low quality. Three meta-analysis have been published on bracing: one shows that bracing does not reduce surgery rates, but studies with bracing plus exercises were not included and had the highest effectiveness; another shows that full time is better than part-time bracing; the last focuses on observational studies following the SRS criteria and shows that not all full time rigid bracing are the same: some have the highest effectiveness, others have less than elastic and nighttime bracing. Two very important RCTs failed in recruitment, showing that in the field of bracing for scoliosis RCTs are not accepted by the patients. Consensuses by the international Society on Scoliosis Orthopedic and Rehabilitation Treatment (SOSORT) show that there is no agree- ment among experts either on the best braces or on their biomechanical action, and that compliance is a matter of clinical more than patients' behavior (there is strong agreement on the management criteria to achieve best results with bracing). A systematic review of all the existing studies shows effectiveness of exercises, and that auto-correction is the main goal of exercises. A systematic review shows that there are no studies on manual treatment. Research on conservative treat- ment of AIS has continuously decreased since the 1980s, but this trend changed only recently. The SOSORT Guidelines offers the actual standard of conservative care.